MedTrace Logo

A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis

NCT00475605 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8071

Last updated 2019-12-18

No results posted yet for this study

Summary

This is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis. Patients whose ages are/were \< 16 years at the time of first tacrolimus ointment exposure are eligible to participate. No drug is distributed during this observational trial.

Conditions

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • LEO Pharma A/S · Medical Expert

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-25
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • United States
  • Austria
  • Canada
  • France
  • Germany
  • Ireland
  • Netherlands
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00475605 on ClinicalTrials.gov